Exscientia plc Investors Alerted by The Gross Law Firm to Consider Lead Plaintiff Appointment Before Deadline

NEW YORK, May 3, 2024 – Investors who hold shares in Exscientia plc EXAI, an Oxford, UK-based artificial intelligence-driven pharmaceutical technology firm, have been alerted by The Gross Law Firm regarding a potential lead plaintiff appointment. The firm has issued a notice calling for shareholders who made EXAI stock purchases during the specified class period to come forward. The deadline set for this action is June 25, 2024, and it is critical for affected shareholders to take timely action to protect their rights.

Who Is Affected?

Shareholders who invested in EXAI during the defined class period and are interested in participating in a potential lawsuit or have questions about their rights and interests with respect to the matter are encouraged to reach out to The Gross Law Firm. Representing investors across the globe, the firm seeks to ensure that the interests of shareholders are upheld, particularly in matters of potential misrepresentation or fraudulent activities that may have affected the value of their investments in EXAI.

Why Contact The Firm?

By contacting The Gross Law Firm, shareholders may be considered for the position of lead plaintiff. A lead plaintiff is typically the movant with the largest financial interest in the relief sought by the class, and they can provide direction in the litigation including the crafting of legal strategy. Putting forward a lead plaintiff is an important step in class-action lawsuits and being appointed can permit a shareholder to work closely with counsel to ensure their voice is significantly heard throughout the legal process.

About Exscientia plc

EXAI is a frontier company in integrating artificial intelligence into the pharmaceutical industry. Headquartered in Oxford, the company stands at the forefront of drug discovery, design, and development, aiming to revolutionize the way pharmaceuticals are developed with the aid of cutting-edge technology.

Important Deadline

Shareholders must bear in mind the impending deadline of June 25, 2024. Failure to act before this date might forfeit your rights as an investor. Those holding shares in EXAI who wish to discuss this action, or have any questions concerning this notice or their rights or interests, should communicate with The Gross Law Firm before the indicated deadline.

investment, shareholders, rights